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Background: Inflammatory responses within the peritoneal cavity may result in en-
dometrial dysfunction in women with endometriosis. The true causes of this disease 
remain poorly understood. It is hypothesized that downstream toll-like receptors 
(TLRs) inflammatory cytokines in response to pathogens may be associated with en-
dometriosis. So, this study was aimed at evaluating the expression of TLRs signaling 
and endometriosis-associated inflammatory responses. 
Methods: Totally, 20 infertile endometriosis patients and 20 normal women under-
going controlled ovarian stimulation were enrolled. The cellular pellet and superna-
tant were obtained by centrifugation of follicular fluid (FF). Evaluation of TLRs and 
their signaling pathway gene expression was performed on cellular pellets using 
quantitative-PCR. The supernatant was used for determination of cytokine protein 
expression by ELISA. The results are expressed as mean±SEM and a p<0.05 was 
considered statistically significant. 
Results: Quantitative-PCR analysis suggested that TLR1, 5, 6, 7, 8, 10, MYD88, 
NF-ĸB, IL-10 and TGF-β genes expression significantly increased in patients com-
pared to the control group (p<0.05). TLR3, 9, INF-β genes expression was signifi-
cantly lower in endometriosis than control group (p<0.05). There was no significant 
difference in the expression of TLR2, TLR4, TIRAP, TRIF, TRAM, and IRF3 be-
tween two groups. Also, significant increase in the levels of IL-6, IL-8 and MIF pro-
tein in FF of endometriosis group was detected in comparison with normal women 
(p<0.05). 
Conclusion: The expression of TLR downstream signaling in the follicular cells can 
initiate inflammatory responses and changes in the FF cytokine profile which in turn 
may induce endometriosis and infertility disorder. 
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ndometriosis is a usual gynecologic disorder 
associated with infertility that affects repro-





enigmatic condition in which endometrial glands 
or stromal cells grow in the extra-uterine locations 
such as fallopian tubes (2). There is no unifying 
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theory that adequately explains the etiology and 
pathophysiology of endometriosis (3). However, 
genetic susceptibilities, hormonal or immunologic 
factors may be involved in the pathogenesis of the 
disease (4). In the last few decades, many more 
studies have illustrated the role of immune re-
sponses in the etiology and pathophysiology of 
endometriosis (5-7). Normally, the immune sys-
tem can clear refluxed endometrial tissues. There-
fore, the predisposition to implantation and growth 
of endometrial cells could be due to dysregulation 
of immune clearance mechanism (4).  
Many studies have reported that engagement of 
toll-like receptors (TLRs) by gram‐positive and 
gram‐negative bacterias in the vaginal route can 
initiate inflammatory responses which leads to the 
promotion of infectious diseases such as endome-
tritis (8, 9). TLRs play essential roles in the innate 
immune system by recognation of pathogen-asso-
ciated molecular patterns (PAMPs) and damage-
associated molecular patterns (DAMPs) (10). The 
expression of TLRs in the human female repro-
ductive system has been established (11). By now, 
ten members of TLR family have been identified 
in human which are expressed on various immune 
and non-immune cells (12-14). TLR1, 2, 4, 5, 6 
and TLR10 are expressed on the cell surface 
where as TLR3, 7, 8 and TLR9 are located in cel-
lular endosome (10, 15). There are published stud-
ies that have reported TLRs 1–10 are expressed in 
the female reproductive tract (2, 16) and their ex-
pression level varies in different phases of men-
strual cycles (17). In vitro studies have shown that 
ligation of TLRs on endometrial epithelial cell 
lines triggers the production of inflammatory cy-
tokines including interleukin 6 (IL-6) and IL-8 
(18). The expression of TLRs 2, 4, 8 and 9 in 
mouse granulosa and cumulus cells has also been 
reported (19). TLRs-ligand interaction activates 
downstream signaling pathways including adaptor 
molecules MYD88, nuclear factor kappa B (NF-
kB) and interferon regulatory factor (IRF) 3 and 7 
that enhance secretion of pro-inflammatory cyto-
kines and chemokines such as interleukins 6, 8, 10 
and macrophage migration inhibitory factor (MIF) 
(20). It was reported that the peritoneal fluid of 
women with endometriosis contained significantly 
elevated levels of the chemokines, monocyte che-
moattractant protein-1 (MCP‐1) and IL‐8 (21). On 
the other hand, the proliferation of human endo-
metrial stromal cells may be inhibited by interleu-
kin-6 (22). Also, the severity of endometriosis is 
correlated with levels of IL-6 in peritoneal fluid 
(23). However, there is no strong evidence to sup-
port it and more detailed studies are needed to 
clarify all aspects of dysregulation of the immune 
system in the development and progress of endo-
metriosis. The aim of the present study was inves-
tigation of changes in TLRs and their signaling 
pathway gene expression in the follicular cells of 
infertile women with endometriosis. 
 
Methods 
Study design: This case-control study was ap-
proved by Ethics Committees of Royan Institute.  
Forty patients (20 infertile endometriosis patients 
and 20 normal women with male factor infertility 
as a control) who attended Reproductive Medicine 
Unit in the Royan Infertility Clinic, Tehran, Iran, 
for intracytoplasmic sperm injection (ICSI) treat-
ment were the subjects of the study. An informa-
tion sheet was offered to all women and informed 
written consent was obtained. The infertile wom-
en aged 20-35 undergoing ICSI treatment with the 
same standard long protocol and patients with 
stage III endometriosis in laparascopic assessment 
were selected. Stage III endometriosis was de-
fined as the presence of endometriomas on the 
ovary (24). Patients with hyper-prolactinemia, poor 
ovarian response and history of ovarian surgery 
and infection were excluded. The anthropometric 
measurements were accomplished, based on body 
mass index [BMI, calculated as weight/ (height)2 
(kg/m2)]. The hormones such as LH, FSH, testos-
terone were also determined. All laboratory par-
ameters were checked in the early follicular phase 
of the menstrual cycle. 
 
Protocol for controlled ovarian stimulation: In this 
study, to minimize bias, all women were adminis-
trated a standard long protocol using GnRH-ago-
nist (Superfact, Aventis, Germany). GnRH-a start-
ed around day 17-19 of the natural menstrual cy-
cle as a pre-treatment. A daily dose of 0.5 mg was 
used subcutaneously when pituitary desensitiza-
tion was confirmed (Endometrial thickness <5 mm 
and serum estradiol level <50 pg/ml), then the 
GnRH-a dose was reduced by one-half and ovari-
an stimulation was initiated. The ovarian stimula-
tion started with a dose of 150-225 IU r-FSH 
(Gonal-F, Merck Serono, Switzerland) concerning 
the patient’s age and was continued until the day 
of ovulatory human chorionic gonadotropin (hCG) 
administration according to the ovarian response. 
When at least two follicles were greater than 18 
mm, 10,000 IU urinary hCG (Choriomon, IBSA, 
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ovulation induction and oocyte retrieval was per-
formed 34-36 hr later (25). 
 
Sample collection: FF aspiration was carried out 
with transvaginal ultrasound guidance aspirating 
the largest follicles (>18 mm) without flashing and 
blood contamination. The follicular fluid (FF) was 
transferred to a sterile Petri dish, then the oocytes 
were removed. The fluid was collected into a 15-
ml conical tube and centrifuged at 300 g for 5 min.  
 
RNA isolation, cDNA synthesis and RT-PCR: The 
supernatant was removed and 1ml of TRI reagent 
(Sigma, Pool, UK) was added to the cell pellet 
and homogenized for total RNA extraction fol-
lowing a standard protocol according to manufac-
turer’s instruction. Obtained total RNA, in both 
groups, was treated three times with DNase I (Fer-
mentase, Germany) to remove genomic DNA con-
tamination from the samples. The first-strand 
cDNA synthesis was performed using oligo (dT) 
primers and reverse transcription was done by 
SuperScript II (Fermentase). Negative controls 
were prepared without the addition of the enzyme 
(Non-reverse transcribed controls, RT controls). 
The RT-PCR was performed using the cDNA of 
each sample. Briefly, the amplification was per-
sistent for 40 cycles under the following setting: 
95C for 30 s, 60-63C (Table 1) for 30 s, and 
72C for 30 s. Β-actin and GAPDH were used as 
internal controls and their expressions were check-
ed between two groups. 
 
Quantitative real-time PCR (QPCR): The Q-PCR 
was performed for evaluating myeloid differentia-
tion primary response protein (MYD88), TIR do-
main containing adaptor protein (TIRAP), TIR-
domain-containing adapter-inducing interferon-β 
(TRIF), TRIF-related adaptor molecule (TRAM), 
NF-ĸB, interferon regulatory factor 3 (IRF3), in-
terferon-β (INF-β), IL-10 and transforming growth 
factor beta (TGF-β) with the CDNA prepared from 
the follicular cells pallet. The forward and reverse 
primers for each gene were designed by Primer-
BLAST (https://www.ncbi.nlm.nih.gov/tools/pri-
mer-blast/) (Table 1). The qPCR reactions were 
carried out in triplicates using an ABI Prism 7300 
Sequence Detector (Applied Biosystems, Foster, 
USA) in a total volume of 20 μl containing 250 ng 
of cDNA, 5 pmol of gene specific primers and 
SYBR green reagent (Applied Biosystems) with 
ROX dye as a passive control for signal intensity. 
The thermal cycle profile included 50 cycles at 
95C for 30 s, 60-63C (Table 1) for 30 s, and 
72C for 30 s (26). Samples were run in triplicate. 
Melting curve analysis was used for th determina-
tion of the specificity of the PCR fragments. All 
Table 1. List of primers 
 
Gene Forward primer (5-3) Reverse primer (3-5) 
Annealing  
temperature (C) 
Product size  
(bp) 
TLR1 GGGTCAGCTGGACTTCAGA AAAATCCAAATGCAGGAACG 63 250 
TLR2 TCGGAGTTCTCCCAGTTCTCT TCCAGTGCTTCAACCCACAA 60 175 
TLR3 GTATTGCCTGGTTTGTTAATTGG AAGAGTTCAAAGGGGGCACT 60 156 
TLR4 TGATGTCTGCCTCGCGCCTG AACCACCTCCACGCAGGGCT 60 98 
TLR5 CACCAAACCAGGGATGCTAT CCTGTGTATTGATGGGCAAA 60 111 
TLR6 GCCACCATGCTGGTGTTGGCT CGCCGAGTCTGGGTCCACTG 60 101 
TLR7 CCTTGAGGCCAACAACATCT GTAGGGACGGCTGTGACATT 63 285 
TLR8 CTTCGATACCTAAACCTCTCTAGCAC AAGATCCAGCACCTTCAGATGA 60 90 
TLR9 TTCCCTGTAGCTGCTGTCC ACAGCCAGTTGCAGTTCACC 60 207 
TLR10 TGCCCACCACAATCTCTTCCATGA AGCAGCTCGAAGGTTTGCCCA 60 184 
MYD 88 GTCTCCTCCACATCCTCCCT TCCGCACGTTCAAGAACAGA 60 82 
TIRAP CCTGCTGAAGAAGCCCAAGA GGTTGTCCTGTGAGGTAGGC 60 83 
TRIF GAAGGAACAGGACACCCGAG TGAGTAGGCTGCGTTCAGTG 60 91 
TRAM TGAAGCCCTCAGAGTCCAGA TCTGCCACATGGCATCTCAG 60 85 
NF-kB CTGGATCTGCTGGTGGACAG CTGTGGCTAGATGCAAGGCT 60 82 
IRF 3 CTTGGTGGAGGGCATGGATT GTTGAGGTGGTGGGGAACAG 60 96 
IFN-β ACGCCGCATTGACCATCTAT GTCTCATTCCAGCCAGTGCT 60 85 
IL-10 AAGACCCAGACATCAAGGCG AGGCATTCTTCACCTGCTCC 60 135 
TGF-β GGAGCAGCTGTCCAACATGA GGGCACGGGTGTCCTTAAAT 60 146 
B-Actin CAAGATCATTGCTCCTCCTG ATCCACATCTGCTGGAAGG 60 90 
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melting curves produced one peak per PCR prod-
uct. Standard curves were obtained using the loga- 
 
rithmic dilution series of total RNA. The efficien-
cy of the RT-PCR was 98%. The qPCR data were 
analyzed using the comparative CT method (27) 
and fold change was calculated as FC–2-∆∆CT.  
 
Immunoassay: The follicular fluid from each pa-
tient was centrifuged at 300 g for 5 min, then the 
supernatant was used to measure the concentra-
tion of IL-6, IL-8, and MIF by commercially en-
zyme-linked immunosorbent assay (ELISA) kits. 
Briefly, this technique uses a microwell plate 
coated with a monoclonal antibody specific for 
human IL-6 (eBioscience, minimal detection level 
<1 pg/ml), human IL-8/NAP-1 (eBioscience, min-
imal detection level <5 pg/ml), and human MIF 
(Glory Science, minimal detection=3 mg/ml). The 
preparation was added to each well and incubated 
at room temperature for 1 hr. Then, plates were 
washed three times using phosphate-buffered sa-
line (PBS). The biotin-conjugated anti-human IL-
6, IL-8, and MIF monoclonal antibody was added 
to each plate. The plates were washed again and 
streptavidin-HRP and tetramethyl-benzidine as a 
substrate was added to each well. Optical density 
(OD) was measured by ELISA reader at 450 nm. 
The concentration of each cytokine was determin-
ed by comparing the optical density of samples. 
 
Statistics: The results were expressed as mean± 
SEM. Statistical analysis was performed by using 
a t-test using SPSS 22 software. The p<0.05 was 
considered significant. For real-time data, 2–∆∆Ct 
was calculated for each gene, then the data was 
analyzed using the GraphPad PISM 8 software.  
 
Ethical consideration: All procedures were ap-
proved by the Ethics Committee of Royan Insti-
tute and informed consent was obtained from each 
patient before the sample collection. 
 
Results 
The demographic and clinical characteristics of 
patients are presented in table 2. The number of 
mature oocyte is significantly lower in endometri-
osis samples compared to the control group. There 
is no significant difference in other items between 
the two groups. 
The quantitative expression profiles of TLR1–10 
genes in follicular cells in both groups are shown 
in figure 1. TLR1, 5, 6, 7, 8 and TLR10 showed a 








Age (Years) 29.78±4.52 30.75±3.89 0.48 
BMI (kg/m2) 24.75±3.19 25.20±4.19 0.70 
LH (mU/ml) 3.41±1.65 5.02±3.39 0.07 
FSH (mU/ml) 6.86±2.80 8.55±5.73 0.23 
LH/FSH ratio 0.55±0.30 0.64±0.33 0.40 
Testosterone (ng/ml) 1.35±0.44 1.31±0.54 0.87 
No. of mature oocytes 5.35±4.5 10.1±1.59 <0.001 
 
Presented as mean±SD and compared by t-test 
BMI: Body Mass Index 
 
Figure 1. QPCR was used to quantify the expression of TLRs mRNA in endometriosis and control groups. Data are presented as 
mean±SEM of normalized expression values against endogenous controls (B-actin and GAPDH mRNA) in endometriosis and control 
group. TLR1, 5, 6, 7, 8 and TLR10 showed a significantly higher expression in endometriosis patients compared with the normal 
women. TLR2 and TLR4 showed no significant difference in both groups. TLR3, 9 showed significantly lower expressions in endo-
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significantly higher expression in endometriosis 
patients compared to the control (p<0.05). The 
fold change and exact p-value of each gene are 
shown in table 3. There was no significant differ-
ence in the expression of TLR2 and 4 in both 
groups. TLR3, 9 showed significantly lower ex-
pressions in endometriosis patients compared with 
the control (p<0.05). The quantitative expression 
profile of MYD88, TIRAP, TRIF, TRAM, NF-
ĸB, IRF3, INF-β, IL-10 and TGF-β genes in fol-
licular cells in both groups are shown in figure 2. 
MYD88, NF-ĸB, IL-10, and TGF-β showed a sig-
nificantly higher expression in endometriosis pa-
tients compared to the control (p<0.05). The ex-
pression of TIRAP, TRIF, TRAM, and IRF3 re-
vealed no significant difference in endometriosis 
patients compared to the control group. The inter-
feron-β (INF-β) showed significantly lower ex-
pression in endometriosis patients compared with 
the control (p<0.05). 
The quantitative analysis of IL-6, IL-8, and MIF 
concentration in FF is shown in figure 3. IL-6, IL-
8, and MIF significantly increased in endometrio-
sis cases as compared with the control (p<0.05). 
Discussion 
Our study was performed to expand our know-
ledge of the molecular aspects of immune re-
sponses in patients with endometriosis. Both anti-
inflammatory cytokines, TGF-β and IL-10 and the 
inflammatory mediators, IL-8, IL-6, MIF, and in-
terferon were investigated as well. 
It is hypothesized that dysregulation of immune 
responses has been involved in the pathophysiol-
ogy of endometriosis-associated infertility (28). 
Accordingly, infertile women with endometriosis 
have a significantly higher expression of TLR1, 5, 
6, 7, 8, 10 and significantly lower expression of 
TLR3, 9 when compared with normal women. 
However, the expression of TLR2 and 4 was not 
significantly different between both groups. A 
significant increase of TLR4 mRNA expression 
was reported in the ectopic endometriotic lesions 
compared to corresponding eutopic tissues by 
Allhorn et al. (29). However, our results indicated 
that expression of TLR4 in follicular cells of 
women with endometriosis was not significant 
compared to the control. 
Emerging evidence reported that some of the 
pro-inflammatory cytokines and chemokines are 
increasing not only in the endometrium but also in 
the peritoneal fluid  and follicular fluid of women 
and animals with endometriosis (30-32). Also, 
many studies have demonstrated pelvic inflamma-
tion that is triggered primarily by bacterial endo-
toxin (Lipopolysacccharide) and is mediated by 
toll‐like receptors and their involvement in the 
development of pelvic endometriosis has been 
shown. Our findings suggested that simultaneous-
ly with TLR expression in the follicular cells, in-
flammatory and anti-inflammatory mediators such 
as IL-8, IL-6, and MIF also increased in follicular 
fluid. Our findings demonstrate the elevated MIF 
protein production in these patients which is con- 
 
sistent with previous studies that have shown ele-
vated MIF in peritoneal fluid (33) and peripheral 
blood of women with endometriosis (34). In-
creased levels of MIF have adverse effects on ca-
pacitation and sperm motility (35). Moreover, 
MIF binding to CD74 and upregulated IL-8 lead 
to regulation of inflammatory and immune re-
sponses (36, 37). Surprisingly, a significant ex-
pression of anti-inflammatory cytokine, TGF- β 
was seen in follicular cells of women with endo-
metriosis in comparison with control group. It has 
been reported that, cell adhesiveness, migration, 
colonization, invasiveness, and development of  
 
Table 3. The fold change and p-value of each gene 
 
Gene Fold change p-value (<0.05) 
TLR1 5.142 0.0009 
TLR2 1.13 0.2711 
TLR3 12.16 0.0001 
TLR4 1.96 0.5239 
TLR5 3.23 0.021 
TLR6 5.95 0.0011 
TLR7 7.07 0.0003 
TLR8 8.33 0.0003 
TLR9 12.931 <0.0001 
TLR10 11.89 0.00001 
MYD88 10.03 0.0028 
TRIF 1.34 0.6701 
TRAM 2.07 0.2839 
TRAP 0.94 0.6086 
NF-kB 13.80 0.0055 
IRF3 1.78 0.5741 
INF-β 6.02 0.0012 
IL-10 5.12 0.0052 
TGF- β 9.77 0.0021 
IL-6 14.75 <0.00001 
IL-8 20.14 <0.00001 
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endometriosis can be increased by high level of 
TGF-β (38). The interaction between macrophag-
es and endometrial stromal cells (EMSs) may 
stimulate the secretion of TGF-β and IL-10 that 
leads to downregulation of NK cells cytotoxicity 
and may promote the development of endometrial 
stripe (EMS) via the immune escape of ectopic 
fragments (39). Accordingly, a significant increase 
Figure 3. IL-6, IL-8 and MIF protein concentration obtained by ELISA in FF of endometriosis and control groups. IL-6, IL-8, and 
MIF showed a significantly higher expression in endometriosis cases compared with the control. Data were analyzed by t-test. The 
level of significance was set at p<0.05 
Figure 2. Q-PCR was used to quantify the expression of MYD88, TIRAP, TRIF, TRAM, NF-ĸB, IRF3, INF-β, IL-10 and TGF-β 
genes in granolosa cells in endometriosis and control groups. Data are presented as mean±SEM of normalized expression values 
against endogenous controls (B-actin and GAPDH mRNA) in POR and control. MYD88, NF-ĸB, IL-10 and TGF-β showed a signifi-
cantly higher expression in endometriosis patients compared with the control. The expression of TIRAP, TRIF, TRAM, and IRF3 
revealed no significant difference in endometriosis patients compared to the control group. INF-β showed significantly lower expres-
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of TGF-β and IL-10 in FF was detected by immu-
noassay analysis. Also, TGF-β is believed to play 
a major role in the etiology of peritoneal endome-
triosis and this may provide an environment fa-
vorable to lesion formation (40, 41). The inter- 
 
action between activated macrophages or maybe 
follicular cells (TLR stimulation via microbial 
products leads to macrophages activation) and 
other stromal cells in women with endometriosis 
downregulates activation of immune cells, possi-
bly by stimulating the secretion of IL-10 and 
TGF-β, and may further trigger the immune es-
cape of ectopic fragments and promote the occur-
rence and the development of endometriosis in 
women (39, 40). TGF-β and IL-10 are secreted by 
many cell types, including macrophages. Inflam-
matory stimuli (IL-2, IL-10, TGF-β), that activate 
macrophages and other cells, such as follicular 
cells enhance the release of active TGF-β and IL-
10. Moreover, TGF-β signalling is a well-studied 
pathway involved in follicular development and 
ovulation (42). Generally, our findings disclosed 
that increased expression of TLRs molecules in 
folicular cells leads to recruitment and increase of 
different adaptor molecules such as MyD88, 
TIRAP, TRAM and TRIF which results in activa-
tion of transcription factors including NF-KB and 
IRFs which in turn induces production of pro-
inflammatory cytokines in follicular fluid. There-
fore, more detailed investigations are needed to 
clarify the role of inflammatory or anti-inflamma-
tory responses in the development of endometrio-
sis lesions.  
 
Conclusion 
Our results suggest that the lack of clearance of 
microbial agents may lead to the identification of 
pathogen-related structures by TLRs which in turn 
triggers the adapter and downstream signaling 
molecules such as NF-KB, MYD-88 and TRIF. 
As a result, TLRs signaling pathway induces pro-
duction of inflammatory cytokines and chemo-
kines especially IL-6, IL-8 and MIF in follicular 
tissues. Increased inflammatory responses and 
changes in the FF cytokine profile may causes or 
worsen endometriosis and infertility.   
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